Top

Published in:

2019 | OriginalPaper | Chapter

8. Chitosan-Based Mucosal Nanovaccines

Authors : Sergio Rosales-Mendoza, Omar González-Ortega

Published in: Nanovaccines

Publisher: Springer International Publishing

Activate our intelligent search to find suitable subject content or patents.

search-config

AI-assisted search

Off

Abstract

The race for vaccine development has as priority the formulation of subunit vaccines capable of developing robust and safe immune responses, which will overcome the disadvantages of the vaccines formulated with whole pathogens, namely high reactogenicity and in some cases the risk to develop the disease to which the vaccine is supposed to protect against. Moreover, the development of efficacious vaccines against non-communicable diseases imposes the challenge of efficiently breaking the immune tolerance against self-antigens. Chitosan is an attractive polymer that has been employed to develop nanovaccines with promising findings in preclinical evaluations. In the present chapter, an overview of the nanovaccines based on chitosan nanoparticles targeting human and animal diseases is presented. Chitosan-based nanovaccines have shown promising efficacy in animal models of several diseases with many of them being highly immunogenic when administered by mucosal routes, which are the most attractive approach for massive and painless immunization. Clinical evaluation of some chitosan-based adjuvants adds potential to this field.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

inform now

previous chapter Carbon Nanotubes-Based Mucosal Vaccines

next chapter Liposome-Based Nanovaccines

Babu A, Ramesh R (2017) Multifaceted applications of chitosan in cancer drug delivery and therapy. Mar Drugs 15(4):E96CrossRef

Biswas S, Chattopadhyay M, Sen KK, Saha MK (2015) Development and characterization of alginate coated low molecular weight chitosan nanoparticles as new carriers for oral vaccine delivery in mice. Carbohydr Polym 121:403–410CrossRef

Bivas-Benita M, Laloup M, Versteyhe S, Dewit J, De Braekeleer J, Jongert E, Borchard G (2003) Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies. Int J Pharm 266(1-2):17–27CrossRef

Borges O, Tavares J, de Sousa A, Borchard G, Junginger HE, Cordeiro-da-Silva A (2007) Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles. Eur J Pharm Sci 32:278–290CrossRef

Brune KD, Howarth M (2018) New routes and opportunities for modular construction of particulate vaccines: stick, click, and glue. Front Immunol 9:1432CrossRef

Caetano LA, Almeida AJ, Gonçalves L (2016) Effect of experimental parameters on alginate/chitosan microparticles for BCG encapsulation. Mar Drugs 14(5):90CrossRef

Chew JL, Wolfowicz CB, Mao HQ, Leong KW, Chua KY (2003) Chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen, Der p 1 for oral vaccination in mice. Vaccine 21(21-22):2720–2729CrossRef

Cordeiro AS, Crecente-Campo J, López-Bouzo B, González SF, de la Fuente M, Alonso MJ (2019) Engineering polymeric nanocapsules for an efficient drainage and biodistribution in the lymphatic system. J Drug Target 2:1–52

Démoulins T, Englezou PC, Milona P, Ruggli N, Tirelli N, Pichon C, Sapet C, Ebensen T, Guzmán CA, McCullough KC (2017) Self-replicating RNA vaccine delivery to dendritic cells. Methods Mol Biol 1499:37–75CrossRef

Denizli M, Aslan B, Mangala LS, Jiang D, Rodriguez-Aguayo C, Lopez-Berestein G, Sood AK (2017) Chitosan nanoparticles for miRNA delivery. Methods Mol Biol 1632:219–230CrossRef

Dubey S, Avadhani K, Mutalik S, Sivadasan SM, Maiti B, Girisha SK, Venugopal MN, Mutoloki S, Evensen Ø, Karunasagar I, Munang’andu HM (2016) Edwardsiella tarda OmpA encapsulated in chitosan nanoparticles shows superior protection over inactivated whole cell vaccine in orally vaccinated fringed-lipped peninsula carp (Labeo fimbriatus). Vaccine 4(4):E40CrossRef

Goldmann K, Ensminger SM, Spriewald BM (2012) Oral gene application using chitosan-DNA nanoparticles induces transferable tolerance. Clin Vaccine Immunol 19(11):1758–1764CrossRef

Harde H, Agrawal AK, Jain S (2014) Development of stabilized glucomannosylated chitosan nanoparticles using tandem crosslinking method for oral vaccine delivery. Nanomedicine 9(16):2511–2529CrossRef

Harde H, Agrawal AK, Jain S (2015a) Tetanus toxoids loaded glucomannosylated chitosan based nanohoming vaccine adjuvant with improved oral stability and immunostimulatory response. Pharm Res 32(1):122–134CrossRef

Harde H, Siddhapura K, Agrawal AK, Jain S (2015b) Divalent toxoids loaded stable chitosan-glucomannan nanoassemblies for efficient systemic, mucosal and cellular immunostimulatory response following oral administration. Int J Pharm 487(1-2):292–304CrossRef

Huang JL, Yin YX, Pan ZM, Zhang G, Zhu AP, Liu XF, Jiao XA (2010) Intranasal immunization with chitosan/pCAGGS-flaA nanoparticles inhibits Campylobacter jejuni in a White Leghorn model. J Biomed Biotechnol 2010:589476

Ilinskaya AN, Dobrovolskaia MA (2016) Understanding the immunogenicity and antigenicity of nanomaterials: past, present and future. Toxicol Appl Pharmacol 299:70–77CrossRef

Jain S, Sharma RK, Vyas SP (2006) Chitosan nanoparticles encapsulated vesicular systems for oral immunization: preparation, in-vitro and in-vivo characterization. J Pharm Pharmacol 58(3):303–310CrossRef

Karch CP, Burkhard P (2016) Vaccine technologies: from whole organisms to rationally designed protein assemblies. Biochem Pharmacol 120:1–14CrossRef

Le Buanec H, Vetu C, Lachgar A, Benoit MA, Gillard J, Paturance S, Aucouturier J, Gane V, Zagury D, Bizzini B (2001) Induction in mice of anti-Tat mucosal immunity by the intranasal and oral routes. Biomed Pharmacother 55(6):316–320CrossRef

Li GP, Liu ZG, Liao B, Zhong NS (2009) Induction of Th1-type immune response by chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen Der p 2 for oral vaccination in mice. Cell Mol Immunol 6(1):45–50CrossRef

Li L, Lin SL, Deng L, Liu ZG (2013) Potential use of chitosan nanoparticles for oral delivery of DNA vaccine in black seabream Acanthopagrus schlegelii Bleeker to protect from Vibrio parahaemolyticus. J Fish Dis 36(12):987–995CrossRef

Li L, Wei Y, Gong C (2015) Polymeric nanocarriers for non-viral gene delivery. J Biomed Nanotechnol 11(5):739–770CrossRef

Li J, Cai C, Li J, Li J, Li J, Sun T, Wang L, Wu H, Yu G (2018) Chitosan based nanomaterials for drug delivery. Molecules 23(10):2661CrossRef

Liu Z, Lv D, Liu S, Gong J, Wang D, Xiong M, Chen X, Xiang R, Tan X (2013) Alginic acid-coated chitosan nanoparticles loaded with legumain DNA vaccine: effect against breast cancer in mice. PLoS One 8(4):e60190CrossRef

Lohcharoenkal W, Wang L, Chen YC, Rojanasakul Y (2014) Protein nanoparticles as drug delivery carriers for cancer therapy. BioMed Res Int 2014:180549CrossRef

Malik B, Goyal AK, Zakir F, Vyas SP (2011) Surface engineered nanoparticles for oral immunization. J Biomed Nanotechnol 7(1):132–134CrossRef

Malik B, Goyal AK, Markandeywar TS, Rath G, Zakir F, Vyas SP (2012) Microfold-cell targeted surface engineered polymeric nanoparticles for oral immunization. J Drug Target 20(1):76–84CrossRef

Malik A1, Gupta M1, Gupta V1, Gogoi H1, Bhatnagar R1 (2018) Novel application of trimethyl chitosan as an adjuvant in vaccine delivery. Int J Nanomedicine 13:7959–7970CrossRef

Mangal S, Pawar D, Agrawal U, Jain AK, Vyas SP (2014) Evaluation of mucoadhesive carrier adjuvant: toward an oral anthrax vaccine. Artif Cells Nanomed Biotechnol 42(1):47–57CrossRef

Mishra N, Khatri K, Gupta M, Vyas SP (2014) Development and characterization of LTA-appended chitosan nanoparticles for mucosal immunization against hepatitis B. Artif Cells Nanomed Biotechnol 42(4):245–255CrossRef

Moran HBT, Turley JL, Andersson M, Lavelle EC (2018) Immunomodulatory properties of chitosan polymers. Biomaterials 184:1–9CrossRef

Neimert-Andersson T, Hällgren AC, Andersson M, Langebäck J, Zettergren L, Nilsen-Nygaard J, Draget KI, van Hage M, Lindberg A, Gafvelin G, Grönlund H (2011) Improved immune responses in mice using the novel chitosan adjuvant ViscoGel, with a Haemophilus influenzae type b glycoconjugate vaccine. Vaccine 29(48):8965–8973CrossRef

Neimert-Andersson T, Binnmyr J, Enoksson M, Langebäck J, Zettergren L, Hällgren AC, Franzén H, Lind Enoksson S, Lafolie P, Lindberg A, Al-Tawil N, Andersson M, Singer P, Grönlund H, Gafvelin G (2014) Evaluation of safety and efficacy as an adjuvant for the chitosan-based vaccine delivery vehicle ViscoGel in a single-blind randomised Phase I/IIa clinical trial. Vaccine 32(45):5967–5974CrossRef

Peng X, Hu X, Salazar MA (2019) First case in China of vaccine-associated poliomyelitis after sequential Inactivated and bivalent oral polio vaccination. Vaccine 37(5):751–754CrossRef

Rajeshkumar S, Venkatesan C, Sarathi M, Sarathbabu V, Thomas J, Anver Basha K, Sahul Hameed AS (2009) Oral delivery of DNA construct using chitosan nanoparticles to protect the shrimp from white spot syndrome virus (WSSV). Fish Shellfish Immunol 26(3):429–437CrossRef

Ramya VL, Sharma R, Gireesh-Babu P, Patchala SR, Rather A, Nandanpawar PC, Eswaran S (2014) Development of chitosan conjugated DNA vaccine against nodavirus in Macrobrachium rosenbergii (De Man, 1879). J Fish Dis 37(9):815–824CrossRef

Rivas-Aravena A, Fuentes Y, Cartagena J, Brito T, Poggio V, La Torre J, Mendoza H, Gonzalez-Nilo F, Sandino AM, Spencer E (2015) Development of a nanoparticle-based oral vaccine for Atlantic salmon against ISAV using an alphavirus replicon as adjuvant. Fish Shellfish Immunol 45(1):157–166CrossRef

Roy K, Mao HQ, Huang SK, Leong KW (1999) Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 5(4):387–391CrossRef

Saeed MI, Omar AR, Hussein MZ, Elkhidir IM, Sekawi Z (2015) Development of enhanced antibody response toward dual delivery of nano-adjuvant adsorbed human Enterovirus-71 vaccine encapsulated carrier. Hum Vaccin Immunother 11(10):2414–2424CrossRef

Shrestha B, Rath JP (2014) Poly(vinyl alcohol)-coated chitosan microparticles act as an effective oral vaccine delivery system for hepatitis B vaccine in rat model. IET Nanobiotechnol 8(4):201–207CrossRef

Tajdini F, Amini MA, Mokarram AR, Taghizadeh M, Azimi SM (2014) Foot and mouth disease virus-loaded fungal chitosan nanoparticles for intranasal administration: impact of formulation on physicochemical and immunological characteristics. Pharm Dev Technol 19(3):333–341CrossRef

Valero Y, Awad E, Buonocore F, Arizcun M, Esteban MÁ, Meseguer J, Chaves-Pozo E, Cuesta A (2016) An oral chitosan DNA vaccine against nodavirus improves transcription of cell-mediated cytotoxicity and interferon genes in the European sea bass juveniles gut and survival upon infection. Dev Comp Immunol 65:64–72CrossRef

Wang X, Zhang X, Kang Y, Jin H, Du X, Zhao G, Yu Y, Li J, Su B, Huang C, Wang B (2008) Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus. Vaccine 26(40):5135–5144CrossRef

Wang G, Pan L, Zhang Y, Wang Y, Zhang Z, Lü J, Zhou P, Fang Y, Jiang S (2011) Intranasal delivery of cationic PLGA nano/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challenge. PLoS One 6(11):e27605CrossRef

Yan J, Chen R, Zhang H, Bryers JD (2018) Injectable biodegradable chitosan-alginate 3D porous gel scaffold for mRNA vaccine delivery. Macromol Biosci 19:e1800242CrossRef

Ye T, Yue Y, Fan X, Dong C, Xu W, Xiong S (2014) M cell-targeting strategy facilitates mucosal immune response and enhances protection against CVB3-induced viral myocarditis elicited by chitosan-DNA vaccine. Vaccine 32(35):4457–4465CrossRef

Zhang H, Cheng C, Zheng M, Chen JL, Meng MJ, Zhao ZZ, Chen Q, Xie Z, Li JL, Yang Y, Shen Y, Wang HN, Wang ZZ, Gao R (2007) Enhancement of immunity to an Escherichia coli vaccine in mice orally inoculated with a fusion gene encoding porcine interleukin 4 and 6. Vaccine 25(41):7094–7101CrossRef

Zhao K, Shi X, Zhao Y, Wei H, Sun Q, Huang T, Zhang X, Wang Y (2011) Preparation and immunological effectiveness of a swine influenza DNA vaccine encapsulated in chitosan nanoparticles. Vaccine 29(47):8549–8556CrossRef

Title: Chitosan-Based Mucosal Nanovaccines
Authors: Sergio Rosales-Mendoza
Omar González-Ortega
Publisher: Springer International Publishing
Book: Nanovaccines
Print ISBN: 978-3-030-31667-9

Electronic ISBN: 978-3-030-31668-6

Copyright Year: 2019
DOI: https://doi.org/10.1007/978-3-030-31668-6_8

Springer Professional

Abstract

Please log in to get access to your license.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Springer Professional "Technik"

Premium Partners